Objectives: 1. Present a simplified approach to access and treat facial aging
2. Rationale for multi-modality approach
3. Key anatomic and regenerative issues of modern facelifting
4. The deep neck
5. Cpmplimentary facial procedures to enhance rejuvenation

Introduction: Facial aging and its treatment is undergoing seismic changes, bringing about tremendous advances in many aspects of facial surgery. Facial rejuvenation and face and neck surgery in particular have seen marked improvements in care with exceptional outcomes that over time may improve.

Materials / method: To summarize a 20 year experience in multi-modality care of facial aging. The main aspects of facial aging are addressed, including sun damage, volume loss and pre-existing soft tissue and bony deficiency and laxity with a continuum of care approach, selecting the best combinations of modalities to improve outcomes. Newer techniques in deep plane, preservation facelift, jawline shaping, including fat grafting and the "Crevasse Procedure" will be presented as will an approach to the deep neck and its contents. Fat grafting is used for anatomic replacement and tissue regeneration.

Results: Over the past 5 years, 505 patients underwent anatomic and regenerative facial fat grafting in combination with deep plane, vertical lifting, jawline shaping with and without deep neck surgery. Approximately 30 percent of patients had submandibular gland reduction. Temporal brow lift, upper and lower blepheroplasty and upper lip lift were frequently performed. In addition, osseous genioplasty was carried out in those patients with severe retrogenia. Laser resurfacing was used in the majority of patients at some time during their treatment. All patients were placed on maintenance treatments.

Conclusion: Multimodality treatment of facial aging with the introduction of proven regenerative medicine and newer skin care longevity agents is our preferred approach.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: co-founder, board member, shareholder, Mage Biotechnologies

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。